ROCKVILLE, Md. (Aug. 16, 2022) — LaVarne A. Burton, President and CEO of the American Kidney Fund (AKF), the nation's leading nonprofit working on behalf of 37 million Americans with kidney disease, issued the following statement about the passage of the Inflation Reduction Act:
"The Inflation Reduction Act, sweeping legislation that addresses health care as well as climate and taxes, contains important provisions impacting millions of Americans who live with life-threatening chronic diseases.
"Kidney disease currently affects 37 million Americans, including nearly 810,000 who are living with kidney failure, which is most often caused by diabetes and/or high blood pressure.
"AKF strongly supports measures included in the Inflation Reduction Act, such as provisions to update Medicare Part D, the continuation of enhanced tax credits for Affordable Care Act plans, increasing access to recommended vaccines for adults enrolled in Medicare and Medicaid, and provisions to make insulin more affordable for Medicare beneficiaries. We thank President Biden for signing this important bill.
"We also urge Congress to prioritize innovation and drug development on behalf of the 37 million Americans with kidney disease and the millions more at risk."
About the American Kidney Fund
The American Kidney Fund (AKF) fights kidney disease on all fronts as the nation’s leading kidney nonprofit. AKF works on behalf of the 37 million Americans living with kidney disease, and the millions more at risk, with an unmatched scope of programs that support people wherever they are in their fight against kidney disease—from prevention through transplant. With programs that address early detection, disease management, financial assistance, clinical research, innovation and advocacy, no kidney organization impacts more lives than AKF. One of the nation’s top-rated nonprofits, AKF invests 97 cents of every donated dollar in programs, earning the highest 4-Star rating from Charity Navigator for 20 years in a row as well as the Platinum Seal of Transparency from Candid, formerly GuideStar.